Open a Free Demat Account !
₹0 AMC & Account Opening Fee
Concord Biotech
NSE: CONCORDBIO
Healthcare
Concord Biotech (NSE: CONCORDBIO) share price today is ₹548.50, down 1.42% from the previous close of ₹556.40, as of 20 Nov 2026, 03:30 pm IST. Concord Biotech is a listed company in the Healthcare sector (Pharmaceuticals & Drugs industry), with a market capitalisation of about ₹12,377 crore.
₹548.507.901.42%(1D)
Performance Stats for Concord Biotech
Day Range
Low: ₹546.10
High: ₹558.00
52 Week Range
Low: ₹493.50
High: ₹807.50
Open Price
551.00Previous Close
556.40Volume
128810.00Open Price
551.00Previous Close
556.40Volume
128810.00Fundamentals of Concord Biotech
ROCE
18.33%
EPS
₹14.2
Dividend Yield
0.74%
P/E Ratio
40.36
P/B Ratio
5.26
Debt to Equity
0
Current Ratio
3.8
Sales Growth
4.59%
Profit Growth
-8.34%
EBIT Growth
-8.08%
Financials of Concord Biotech
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Concord Biotech
About Concord Biotech
Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies. Thereafter, name of the Company was chan...
Read more
Similar Sector Stocks
| Stocks | CMP |
|---|---|
| Aarey Drugs And Pharm | ₹115.9 3.3% |
| Aarti Drugs | ₹484.5 2.89% |
| Aarti Pharmalabs | ₹987 3.67% |
| Abbott India | ₹26490 3.09% |
Most Viewed Stocks
Sorry, option data not Found For this Stock :(
Events Related to Concord Biotech
Bonus
Nov 4, 2026
Board Meeting
Oct 27, 2026
Board Meeting
Sep 23, 2026
Board Meeting
Jul 31, 2026
AGM
Jul 31, 2026
News About Concord Biotech
Five Stocks To Buy: Paytm, FirstCry, Concord Biotech And More | September 15
Sep 15, 2026
Market Trading Guide: Hindustan Copper among 2 stock recommendations for Tuesday
Aug 17, 2026
Stock Picks Today: SBI, HDFC AMC, Nestle, Hero Moto, Kajaria, Syngene, Concord Biotech, And More On Brokerages" Radar
Jun 25, 2026
Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tablets
Jun 10, 2026
Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspension
Jun 3, 2026

